SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Recro Pharma, Inc. (REPH)

REPH RSS Feed
Add REPH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/29/2016 5:48:51 PM - Followers: 4 - Board type: Free - Posts Today: 0
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially for acute pain following surgery.

Our lead product, an intranasal formulation of dexmedetomidine, or Dex-IN, has completed a Phase Ib placebo controlled, proof of concept trial demonstrating pain relief. We have studied various dosage forms of Dex in eight completed clinical studies, two of which were placebo controlled trials that demonstrated meaningful pain relief. As our product candidates are not in the opioid class of drugs, we expect to overcome many of the side effects associated with commonly prescribed opioid therapeutics, including addiction, constipation and respiratory distress while maintaining analgesic, or pain relieving, effect. We are ready to begin a Phase IIb trial with Dex-IN in patients experiencing post-operative pain. We believe Dex-IN could provide an attractive alternative pain medication to opioids for the more than 50 million surgical procedures that require post-operative pain medication. If approved, Dex-IN would also be the first and only approved acute pain drug in its class of drugs.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
REPH
Current Price
Volume:
Bid Ask Day's Range
SureTrader
REPH News: Statement of Changes in Beneficial Ownership (4) 12/05/2016 04:48:58 PM
REPH News: Statement of Changes in Beneficial Ownership (4) 12/05/2016 04:48:06 PM
REPH News: Statement of Changes in Beneficial Ownership (4) 12/05/2016 04:47:38 PM
REPH News: Statement of Changes in Beneficial Ownership (4) 12/05/2016 04:47:09 PM
REPH News: Securities Registration Statement (s-1) 12/01/2016 08:14:32 AM
PostSubject
#60   http://marketexclusive.com/recro-pharma-inc-nasdaqreph-heres-whats-next/41372/ snippertrader 11/29/16 05:48:51 PM
#59   http://www.smarteranalyst.com/2016/11/28/stock-update-nasdaqreph-heres-recro-pha snippertrader 11/28/16 11:30:07 PM
#58   P3 data was widely expected to be positive IMO. NASDAQjack 11/28/16 09:20:59 AM
#57   It's time for REPH to shine again! tjguy 06/30/16 12:27:11 AM
#56   $REPH recent news/filings stocktrademan 11/21/15 02:30:35 PM
#54   $REPH recent news/filings stocktrademan 11/13/15 11:21:47 AM
#53   $REPH recent news/filings stocktrademan 09/04/15 03:48:12 PM
#52   Anemic volume, no more pump posts. Ahh ain't protagonist12 07/30/15 01:07:58 PM
#51   Looking for a retrace dippyfloppity 07/17/15 02:19:31 PM
#50   HUGE ANALYST RATING > Thomson Reuters gives REPH crudeoil24 07/17/15 12:03:33 PM
#49   7 Million float > moves easily! crudeoil24 07/17/15 09:41:07 AM
#48   Moving up nicely in PM! crudeoil24 07/17/15 09:14:17 AM
#47   REPH is a great $$$$$ opportunity. crudeoil24 07/17/15 09:13:39 AM
#46   Some folks, and shorts that are negative on crudeoil24 07/17/15 09:13:11 AM
#45   HUGE UPSIDE TODAY!!!!! crudeoil24 07/17/15 09:01:23 AM
#44   And why do you think that? Just based protagonist12 06/22/15 05:56:14 PM
#43   Next leg to $ 25 johnstockmaster 06/22/15 02:20:15 PM
#42   damn screwed myself. I sold at 9.77 and lmbarns 06/08/15 07:30:13 PM
#41  Restored $REPH recent news/filings stocktrademan 06/08/15 02:45:10 PM
#40   Help me understand.... lmbarns 06/08/15 09:41:38 AM
#39   $REPH recent news/filings stocktrademan 05/20/15 12:28:59 PM
#38   Clinical trials reports next month? johnstockmaster 05/18/15 12:58:33 PM
#37   Second leg begins to $ 20 johnstockmaster 05/13/15 01:13:11 PM
#36   No worries the company is in much better johnstockmaster 05/06/15 07:48:13 AM
#35   REPH churning and burning... Too much negativity surrounding protagonist12 05/01/15 05:31:22 PM
#34   Churning in this range to move past 20$ soon johnstockmaster 04/26/15 05:42:34 AM
#33   I bought this on a simulation account and letj21 04/13/15 10:00:13 AM
#32   I think FDA guys are better expert to johnstockmaster 04/10/15 08:38:54 AM
#31   Dex-In trial in limbo, reduction of patient enrollment protagonist12 04/09/15 01:34:56 PM
#30   Here is the link http://finance.yahoo.com/news/recro-pharma-announces-going-pha johnstockmaster 04/09/15 07:46:06 AM
#29   Thanks for the heads up. Could you post Ado Trade 04/09/15 07:43:17 AM
#28   PR out encouraging trial results next leg begins johnstockmaster 04/09/15 07:40:11 AM
#27   It will come fast two analysts have given johnstockmaster 03/25/15 12:52:09 PM
#26   REPH is taking off! My current short term Ado Trade 03/25/15 10:27:02 AM
#25   I hope so. I'd be able to retire Ado Trade 03/23/15 01:26:10 PM
#24   Target $ 33 in next eight weeks johnstockmaster 03/23/15 01:17:55 PM
#23   2 Bounces off the 15 minute 100 sma Ado Trade 03/22/15 03:41:21 PM
#22   REPH protagonist12 03/17/15 02:16:10 PM
#21   Told you buddy no looking back till $30 johnstockmaster 03/17/15 04:50:06 AM
#20   Watch for the skie johnstockmaster 03/16/15 07:59:51 AM
#19   Should come back to earth as liquidity dries up. protagonist12 03/13/15 05:12:49 PM
#18   This will move fast low float johnstockmaster 03/13/15 07:48:14 AM
#17   No downward trend just watch $ 30 in johnstockmaster 03/12/15 01:35:46 PM
#16   shorted $REPH is looking really heavy! and PennyStockpick 03/12/15 10:10:44 AM
#15   $REPH short, looks like its starting a downward trend. PennyStockpick 03/11/15 03:49:57 PM
#14   First resistance $ 10 johnstockmaster 03/11/15 11:32:11 AM
#13   Nice gap and run play the last 2 runningwithscissors 03/10/15 08:11:11 PM
#12   They are hemorrhaging cash(i.e. secondary already in the protagonist12 03/10/15 05:38:25 PM
#11   $REPH chart - huge 2 day move past ospreyeye 03/10/15 04:02:36 PM
#10   Has been a nice 2-day play but looking runningwithscissors 03/10/15 01:59:48 PM
PostSubject